Erin M Mobley1, Ginny L Ryan2, Amy E Sparks2, Varun Monga3, William W Terry4. 1. Department of Health Management and Policy, College of Public Health, University of Iowa, Iowa City, Iowa. 2. Department of Obstetrics and Gynecology, Reproductive Endocrinology and Infertility, University of Iowa Hospitals and Clinics, Iowa City, Iowa. 3. Department of Internal Medicine, Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, Iowa. 4. Department of Pediatrics, Hematology Oncology, University of Iowa Hospitals and Clinics, Stead Family Children's Hospital, Iowa City, Iowa.
Abstract
Purpose: Fertility preservation before therapy is underutilized for those diagnosed with cancer as an adolescent or young adult (AYA). The purpose of this study was to describe factors impacting utilization of fertility preservation consultations and procedures among AYAs at the University of Iowa Health Care (UIHC). Methods: Patients were identified by the oncology registry at UIHC. Disease site, histology, date of diagnosis, sex, race, ethnicity, insurance, and zip code data were gathered by the registrars. UIHC's electronic medical record was queried for fertility preservation consultation. The Reproductive Endocrinology and Infertility clinical database captured information about patients who underwent fertility preservation. Rural-urban commuting area codes measured rurality. Descriptive statistics and multivariate linear probability models were used to predict the probability of fertility preservation consultation and procedure. Results: From 2008 to 2017, 2932 AYAs were treated for an invasive malignancy at UIHC. Of the 440 (15%) who received a fertility preservation consultation, 156 (5%) underwent a fertility preservation procedure. Multivariate analyses showed that AYAs with public insurance coverage, those diagnosed with central nervous system (CNS) disease or melanoma, and those >30 years old at diagnosis had a significant decrease in the percentage point probability of having a consultation. The percentage point probability of undergoing a procedure was decreased for female patients, those with melanoma or carcinoma, those seen by a pediatric-based provider, and those diagnosed after 25 years of age. Conclusion: This study has important implications for practice and policy, particularly regarding insurance coverage and patient and provider characteristics leading to fertility preservation consultations and procedures for AYAs with cancer.
Purpose: Fertility preservation before therapy is underutilized for those diagnosed with cancer as an adolescent or young adult (AYA). The purpose of this study was to describe factors impacting utilization of fertility preservation consultations and procedures among AYAs at the University of Iowa Health Care (UIHC). Methods:Patients were identified by the oncology registry at UIHC. Disease site, histology, date of diagnosis, sex, race, ethnicity, insurance, and zip code data were gathered by the registrars. UIHC's electronic medical record was queried for fertility preservation consultation. The Reproductive Endocrinology and Infertility clinical database captured information about patients who underwent fertility preservation. Rural-urban commuting area codes measured rurality. Descriptive statistics and multivariate linear probability models were used to predict the probability of fertility preservation consultation and procedure. Results: From 2008 to 2017, 2932 AYAs were treated for an invasive malignancy at UIHC. Of the 440 (15%) who received a fertility preservation consultation, 156 (5%) underwent a fertility preservation procedure. Multivariate analyses showed that AYAs with public insurance coverage, those diagnosed with central nervous system (CNS) disease or melanoma, and those >30 years old at diagnosis had a significant decrease in the percentage point probability of having a consultation. The percentage point probability of undergoing a procedure was decreased for female patients, those with melanoma or carcinoma, those seen by a pediatric-based provider, and those diagnosed after 25 years of age. Conclusion: This study has important implications for practice and policy, particularly regarding insurance coverage and patient and provider characteristics leading to fertility preservation consultations and procedures for AYAs with cancer.
Entities:
Keywords:
fertility preservation; insurance coverage; oncofertility; referral and consultation; survivorship
Authors: Tobias S Köhler; Laxmi A Kondapalli; Amul Shah; Sarah Chan; Teresa K Woodruff; Robert E Brannigan Journal: J Assist Reprod Genet Date: 2010-11-26 Impact factor: 3.412
Authors: Anne-Lotte L F van der Kooi; Marry M van den Heuvel-Eibrink; Sjoerd A A van den Berg; Wendy van Dorp; Saskia M F Pluijm; Joop S E Laven Journal: J Adolesc Young Adult Oncol Date: 2019-01-31 Impact factor: 2.223
Authors: Kiki M G J Wigny; Wendy van Dorp; Anne-Lotte L F van der Kooi; Yolanda B de Rijke; Andrica C H de Vries; Marij Smit; Saskia M F Pluijm; Erica L T van den Akker; Rob Pieters; Joop S E Laven; Marry M van den Heuvel-Eibrink Journal: Hum Reprod Date: 2016-09-28 Impact factor: 6.918
Authors: Kee Kiat Yeo; Darcy E Burgers; Katelynn Brodigan; Karen Fasciano; A Lindsay Frazier; Katherine E Warren; David A Reardon Journal: Neurooncol Pract Date: 2021-02-18